Correlation Between Integrated Biopharma and Arcadia Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Integrated Biopharma and Arcadia Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Integrated Biopharma and Arcadia Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Integrated Biopharma and Arcadia Biosciences, you can compare the effects of market volatilities on Integrated Biopharma and Arcadia Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Integrated Biopharma with a short position of Arcadia Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Integrated Biopharma and Arcadia Biosciences.

Diversification Opportunities for Integrated Biopharma and Arcadia Biosciences

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Integrated and Arcadia is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Integrated Biopharma and Arcadia Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Arcadia Biosciences and Integrated Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Integrated Biopharma are associated (or correlated) with Arcadia Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Arcadia Biosciences has no effect on the direction of Integrated Biopharma i.e., Integrated Biopharma and Arcadia Biosciences go up and down completely randomly.

Pair Corralation between Integrated Biopharma and Arcadia Biosciences

If you would invest  836.00  in Arcadia Biosciences on November 27, 2024 and sell it today you would lose (443.00) from holding Arcadia Biosciences or give up 52.99% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Integrated Biopharma  vs.  Arcadia Biosciences

 Performance 
       Timeline  
Integrated Biopharma 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Integrated Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable fundamental drivers, Integrated Biopharma is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.
Arcadia Biosciences 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Arcadia Biosciences are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat fragile fundamental indicators, Arcadia Biosciences sustained solid returns over the last few months and may actually be approaching a breakup point.

Integrated Biopharma and Arcadia Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Integrated Biopharma and Arcadia Biosciences

The main advantage of trading using opposite Integrated Biopharma and Arcadia Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Integrated Biopharma position performs unexpectedly, Arcadia Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arcadia Biosciences will offset losses from the drop in Arcadia Biosciences' long position.
The idea behind Integrated Biopharma and Arcadia Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Global Correlations
Find global opportunities by holding instruments from different markets
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
CEOs Directory
Screen CEOs from public companies around the world